Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• Wellness for a Life Well-lived, Even With Rheumatic Disease
• ACP: Trump’s Rescission Package Would Harm Public Health
• CreakyJoints Releases Patient-centered Gout Guidelines
• Ethnicity, Hypertension Predict Gout Risk, Unexplained by Urate Level
• Experts say Trump’s Plan to Lower Drug Prices Misses Mark, Unlikely to Work
• Gout Not Linked to Increased Risk for Bone Fracture
• FDA Approves Actemra Subcutaneous Injection for Polyarticular JIA
• FDA Declines Proposed Rituxan Biosimilar From Sandoz
• Otezla Safe, Effective as Monotherapy for Patients With PsA
• Pilot Study To Assess Bone Effects of Cosentyx in Ankylosing Spondylitis
• Wellness and Rheumatology: Is it Important and Whose Job is it to Achieve? Leonard H. Calabrese, DO
• Ace the Case: 60-Year-Old Woman With Recurrent Infections and Bronchitis
• EULAR Addresses Arterial Involvement in Updated Behçet’s Syndrome Recommendations
• EULAR Releases Pain Management Recommendations for OA, Inflammatory Arthritis
• Actemra for Systemic JIA Yields 75% Remission Rate After 1 Year
• Blacks With Lupus Have Higher Comorbidity Burden Than Whites
• Long-term TNF Inhibitor Retention High in Spondyloarthritis
• Lost Productivity Costs High for SLE, Sjögren’s, Systemic Sclerosis
• Lymphoma Rates in Xeljanz Clinical Trials for RA Stable
• Patient’s Relationship With Rheumatologist Affects Perception of Medication
• Widespread Pain More Prevalent in Women With Spondyloarthritis
• Meet the Board: Stanley Cohen, MD, Strikes Balance of Academic Focus With Private Practice
• MIV-711 Fails to Meet Primary Pain Endpoint in Knee OA
• Step Rate Linked With Knee Cartilage Damage in Women
• Patients With Multiple Autoimmune Diseases Have Unique Concerns, Physician Needs
• NSAIDS, Calcium Supplements May Exacerbate SLE Comorbidities
• BE ACTIVE: IL-17F, IL-17A Blockade May ‘Push the Envelope’ for PsA Treatment
• ‘Replacing Prednisone’ Remains Top Priority for Emerging Vasculitis Therapies
• CANTOS: ‘Inflammation is the New Cholesterol’ to Reduce CV Risk
• Concerns Remain Over OA-related Morbidity, Mortality After OARSI White Paper
• SAMBA: Integrated Model Improves Quality of Care for Hip/Knee OA
• Duration of Knee, Hip OA May Increase Cardiovascular Mortality
• Where Change is the NORM: Guiding Rheumatology Practice Managers Through a Field in Flux
• ACR Develops Rheumatology Training Tool for NPs, PAs
• ACR Warns CMS Against Extending Duration of Short-term Insurance Plans
• ‘Right to Try’ Impact on Patients Uncertain
• Trump Unveils Long-Promised Plan to Lower Drug Prices